December 13, 2006 09:07 ET

Theratechnologies Chooses SOLABS' Software System

MONTREAL, QUEBEC--(CCNMatthews - Dec. 13, 2006) - "Time-to-market for therapeutic products must be optimized. Any time-saving that can be made in this vital R&D phase pays big dividends", stated Richard Fecteau, President & CEO of SOLABS. This was just one of the stated reasons why Theratechnologies, a key biopharmaceutical company, chose SOLABS GxP to handle their document and workflow management.

"Our objective was to streamline and automate a number of key processes, such as protocols, study reports, quality processes and training records" said Ms Nadine Bouchard, Director of Compliance and Associate, Regulatory Affairs. "SOLABS was able to bring to us a schedule that was consistent with our objectives. Their knowledge of the GxP (regulated) environment meant that we could start work almost immediately".

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization.

SOLABS is a practice-based solution company focused on documents, workflow and records management in the Pharmaceutical/Biotech industry. SOLABS helps clients to recognize regulatory compliance as a strategic advantage.

Contact Information